Search company, investor...

Predict your next investment

Johnson & Johnson company logo
Corporation
HEALTHCARE | Medical Product Distribution
jnj.com

See what CB Insights has to offer

Investments

95

Portfolio Exits

49

Partners & Customers

10

Service Providers

1

About Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) is a multi-national manufacturer of pharmaceutical, diagnostic, therapeutic, surgical, and biotechnology products, as well as personal hygiene products. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Headquarters Location

One Johnson & Johnson Plaza

New Brunswick, New Jersey, 08933,

United States

732-524-2455

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Johnson & Johnson

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Johnson & Johnson in 9 Expert Collections, including Beauty & Personal Care.

B

Beauty & Personal Care

65 items

Startups in the beauty & personal care space, including cosmetics brands, shaving startups, on-demand beauty services, salon management platforms, and more.

S

Synthetic Biology

382 items

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

C

Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

D

Diabetes

1,899 items

Johnson & Johnson Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Johnson & Johnson Rank

Latest Johnson & Johnson News

Johnson & Johnson Posts Higher Quarterly Sales Despite Strong Dollar

Oct 18, 2022

Johnson & Johnson Posts Higher Quarterly Sales Despite Strong Dollar Healthcare-products firm trims full-year sales outlook after foreign-exchange reduced quarterly sales by 6% J&J posted a quarterly profit of $4.46 billion, or $1.68 a share, up from $3.67 billion, or $1.37 a share, a year earlier. FILE Photo: Mike Segar/REUTERS print (2 minutes) Johnson & Johnson posted higher sales for the recently ended quarter even as the stronger U.S. dollar dented results. The New Brunswick, N.J., healthcare-products company on Tuesday lowered its full-year sales guidance on the Continue reading your article with a WSJ membership Back to Top « Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

Johnson & Johnson Investments

95 Investments

Johnson & Johnson has made 95 investments. Their latest investment was in OrthoSpin as part of their Series B on March 3, 2020.

CBI Logo

Johnson & Johnson Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/31/2020

Series B

OrthoSpin

$5M

Yes

10

11/14/2019

Corporate Minority - IV

Founders Factory

Yes

1

7/18/2018

Corporate Minority

S-Biomedic

Yes

3

2/2/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/17/2015

Corporate Minority

Subscribe to see more

Subscribe to see more

10

Date

3/31/2020

11/14/2019

7/18/2018

2/2/2017

12/17/2015

Round

Series B

Corporate Minority - IV

Corporate Minority

Series A

Corporate Minority

Company

OrthoSpin

Founders Factory

S-Biomedic

Subscribe to see more

Subscribe to see more

Amount

$5M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

1

3

10

10

Johnson & Johnson Portfolio Exits

49 Portfolio Exits

Johnson & Johnson has 49 portfolio exits. Their latest portfolio exit was OrthoSpin on November 04, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/4/2021

Acquired

$99M

10

11/1/2021

Divestiture

Johnson & Johnson - Coach, Elastikon, and Zonas Brands

$99M

6

8/27/2019

Acquired - III

$99M

3

3/16/2018

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

3/16/2018

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/4/2021

11/1/2021

8/27/2019

3/16/2018

3/16/2018

Exit

Acquired

Divestiture

Acquired - III

Divestiture

Acq - Fin

Companies

Johnson & Johnson - Coach, Elastikon, and Zonas Brands

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

10

6

3

10

10

Johnson & Johnson Acquisitions

60 Acquisitions

Johnson & Johnson acquired 60 companies. Their latest acquisition was Abiomed on November 01, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/1/2022

$99M

Acq - Pending

2

6/7/2022

$99M

Acquired Unit

1

8/19/2020

Series C

$99M

$45.68M

Acq - P2P

20

12/20/2019

Other

Subscribe to see more

$99M

Subscribe to see more

10

12/20/2019

Series B

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

11/1/2022

6/7/2022

8/19/2020

12/20/2019

12/20/2019

Investment Stage

Series C

Other

Series B

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$45.68M

$99M

Note

Acq - Pending

Acquired Unit

Acq - P2P

Subscribe to see more

Subscribe to see more

Sources

2

1

20

10

10

Johnson & Johnson Partners & Customers

10 Partners and customers

Johnson & Johnson has 10 strategic partners and customers. Johnson & Johnson recently partnered with Munster Technological University on September 9, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

9/26/2022

Partner

Ireland

Johnson & Johnson expands WiSTEM2D programme to MTU

Johnson & Johnson has expanded its WiSTEM2D programme in partnership with Munster Technological University .

1

8/9/2022

Partner

United States

HCA Healthcare Announces Collaboration With Johnson & Johnson to Address Key Healthcare Clinical and Industry Issues

HCA Healthcare , Inc. , one of the nation 's leading healthcare providers , today announced that it will collaborate with Johnson & Johnson to address key healthcare industry issues .

5

6/27/2022

Partner

United Arab Emirates

Emirates Health Services, Johnson & Johnson partner to boost healthcare sector

Emirates Health Services , Johnson & Johnson partner to boost healthcare sector

1

6/7/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

6/7/2022

Client

United States

Subscribe to see more

Subscribe to see more

10

Date

9/26/2022

8/9/2022

6/27/2022

6/7/2022

6/7/2022

Type

Partner

Partner

Partner

Partner

Client

Business Partner

Country

Ireland

United States

United Arab Emirates

United States

United States

News Snippet

Johnson & Johnson expands WiSTEM2D programme to MTU

Johnson & Johnson has expanded its WiSTEM2D programme in partnership with Munster Technological University .

HCA Healthcare Announces Collaboration With Johnson & Johnson to Address Key Healthcare Clinical and Industry Issues

HCA Healthcare , Inc. , one of the nation 's leading healthcare providers , today announced that it will collaborate with Johnson & Johnson to address key healthcare industry issues .

Emirates Health Services, Johnson & Johnson partner to boost healthcare sector

Emirates Health Services , Johnson & Johnson partner to boost healthcare sector

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

5

1

10

10

Johnson & Johnson Service Providers

1 Service Provider

Johnson & Johnson has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acq - P2P

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Johnson & Johnson Team

152 Team Members

Johnson & Johnson has 152 team members, including current Executive Vice President, Vanessa Broadhurst.

Name

Work History

Title

Status

Vanessa Broadhurst

Executive Vice President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Vanessa Broadhurst

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Executive Vice President

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Johnson & Johnson to Competitors

V
Vertos Medical

Vertos Medical is a medical device company committed to developing minimally invasive treatments for lumbar spinal stenosis (LSS). Its proprietary technologies include mild®, which offers a safe, outpatient, minimally invasive, fluoroscopically guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. LSS is primarily a degenerative, age-related narrowing of the lower spinal canal that causes symptoms of pain and numbness in the lower back, legs, or buttocks. mild® treats this condition by restoring space in the spinal canal using specialized mild® devices to remove hypertrophic ligamentum flavum through a 5.1 mm treatment portal. Clinical trials show that mild® can help LSS patients stand longer and walk farther with less pain1, and no major device-related complications have been reported.2

Nexa3D Logo
Nexa3D

Nexa3D is a 3D printer using LSPc technology. It is an industrial-grade Stereolithography 3D printer powered by a structured light matrix capable of reaching top speed of 1 cm per minute.

Printerprezz Logo
Printerprezz

PrinterPrezz is a medical technology company that combines 3D printing with nanotechnologies to address the needs of the spine medical device market.

H
HeyGears

HeyGears is a manufacturer of advanced industrial 3D printers. Its printers are capable of printing medical grade equipment.

N
Neo

Neo develops solutions and products to improve the outcomes and performance of spinal surgery.

Carbon Logo
Carbon

Carbon is a 3D printing company that works at the intersection of hardware, software, and molecular science. Its SpeedCell is a system of connected manufacturing unit operations that enables repeatable production of end-use parts with industrial-grade materials. It caters mainly to the automotive, consumer, industrial life sciences, and dental industries. The company was founded in 2013 and is based in Redwood City, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.